Status:
RECRUITING
Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study)
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
National Institutes of Health (NIH)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
Fibroid
Leiomyoma
Eligibility:
FEMALE
18-55 years
Brief Summary
The investigators are evaluating the role of senescent cells in uterine fibroids.
Detailed Description
Uterine fibroids are prevalent tumors of uterus characterized by excessive fibrotic tissues. Using new cutting-edge computational methods, the investigators have found that small groups of senescent c...
Eligibility Criteria
Inclusion
- Subjects must be women above the age of ≥18 - ≤55 years.
- Women with suspected uterine fibroids.
- Subject must be or have been sexually active or have had a previous vaginal exam that used a speculum.
- Subject must be able to understand, read and speak English or Spanish and subsequently, be able to understand what she is consenting to in terms of procedures and use/disclosure of protected health information.
Exclusion
- Unwilling to sign the consent form or complete questionnaire.
- Pregnancy.
- Cancer of the uterus
Key Trial Info
Start Date :
November 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06135870
Start Date
November 1 2023
End Date
December 31 2027
Last Update
December 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins Hospital
Baltimore, Maryland, United States, 21287